Last reviewed · How we verify
NCT06384703
The Relationship Between Microbiota and Coronary Ectasia
trial testing Taking blood for kit study in Coronary Ectasia in 2 participants. Completed in 18 June 2021.
25 April 2021
Quick facts
| Lead sponsor | Konya Beyhekim Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2 |
| Start date | 3 November 2020 |
| Primary completion | 25 April 2021 |
| Estimated completion | 18 June 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Taking blood for kit study
Conditions studied
- Coronary Ectasia — all drugs for Coronary Ectasia →
- Microbial Disease — all drugs for Microbial Disease →
Sponsor
Konya Beyhekim Training and Research Hospital
Who can join
18 and older, any sex, with Coronary Ectasia or Microbial Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06384703
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Konya Beyhekim Training and Research Hospital trials
Trials by the same sponsor.
- NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
- NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
- NCT07303634 — Effects of the 4-7-8 Breathing Technique on Postoperative Pain Scores, Anxiety, and Sleep Quality in Patients · not yet recruiting
- NCT07256522 — Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger · NA · recruiting
- NCT07324486 — Postoperative Analgesic Efficacy Between Adductor Canal Block + IPACK Block and Adductor Canal Block + Genicular Nerve B · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06384703 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Konya Beyhekim Training and Research Hospital
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06384703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing